Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases respond to MCL-1 antagonism plus regorafenib in vivo.
Saved in:
| Title: | Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases respond to MCL-1 antagonism plus regorafenib in vivo. |
|---|---|
| Authors: | Ji, Yanhao1 (AUTHOR), Harris, Michael A.1,2 (AUTHOR), Newton, Lucas M.1,3 (AUTHOR), Harris, Tiffany J.4 (AUTHOR), Fairlie, W. Douglas1,4,5 (AUTHOR), Lee, Erinna F.1,4,5 (AUTHOR), Hawkins, Christine J.1,2 (AUTHOR) c.hawkins@latrobe.edu.au |
| Source: | BMC Cancer. 11/4/2024, Vol. 24 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-024-13088-7 |